The simple answer is yes, $0.20 can be done during the summer.
It really is dependent on how rapid the sales growth has been during the first quarter of this year. I have put together alot of projections, particularly for the European market (Universal Healthcare would seem to be a great fit for endoscopy/ductscopy) once we have CE Mark certification.
I could go much farther will it all but for example sake.
If the first quarter numbers come back with say sales of $50K in Jan, $75K Feb, $125-150K Mar (estimating these figures off of sales for Oct/Nov adjusted for growth using the Mammoview 183% sales growth figure) and this could presumably be a low ball projection. This would set the stage perfectly for the 2nd quarter of this year. This sales growth does not include the recent new product line (already has access to global market) or veterinary product line division (multi billion dollar industry and growing).
GLTA